Skip to main content
. 2015 Mar 24;6(2):101–111. doi: 10.1007/s13300-015-0106-2

Table 1.

Coformulation versus pre-mixed preparation

Characteristic Coformulation Pre-mixed preparation
Definition Formulation of two separate components, which maintain distinct identity Mixture of two components, which are unable to maintain distinct identity
Appearance Clear Cloudy
Proportion Pre-determined Pre-determined
Pharmacokinetics/pharmacodynamics Both components maintain distinct PK/PD profiles PK/PD profile of both components may merge
Efficacy Both components achieve efficacy at targeted endpoint Both components often achieve targeted end points
Scope Allows coformulation of separate classes of drugs Does not allow mixing of different classes of drugs
Examples Insulin degludec + insulin aspart; insulin degludec + liraglutide; insulin glargine + lixisenatide Biphasic human insulin; biphasic insulin aspart; biphasic insulin lispro

PD pharmacodynamics, PK pharmacokinetics